| Product Code: ETC7664677 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a negative CAGR from 2020 to 2024, the import shipments of viral vectors and plasmid DNA into Israel saw a notable growth rate of 8.63% in 2024. The top exporting countries to Israel in this sector were Switzerland, USA, Germany, China, and Belgium, indicating a diverse source of imports. The high Herfindahl-Hirschman Index (HHI) concentration suggests a competitive market with significant players dominating the import landscape, paving the way for potential strategic partnerships and market expansions in the future.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Viral Vectors and Plasmid DNA Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Viral Vectors and Plasmid DNA Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Viral Vectors and Plasmid DNA Market - Industry Life Cycle |
3.4 Israel Viral Vectors and Plasmid DNA Market - Porter's Five Forces |
3.5 Israel Viral Vectors and Plasmid DNA Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Israel Viral Vectors and Plasmid DNA Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Israel Viral Vectors and Plasmid DNA Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in gene therapy and biotechnology sectors in Israel |
4.2.2 Growing investments in healthcare and life sciences industries in Israel |
4.2.3 Rising demand for viral vectors and plasmid DNA in gene therapy applications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and use of viral vectors and plasmid DNA in Israel |
4.3.2 High costs associated with the production and development of viral vectors and plasmid DNA products |
5 Israel Viral Vectors and Plasmid DNA Market Trends |
6 Israel Viral Vectors and Plasmid DNA Market, By Types |
6.1 Israel Viral Vectors and Plasmid DNA Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Viral Vectors and Plasmid DNA Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Israel Viral Vectors and Plasmid DNA Market Revenues & Volume, By Plasmid DNA, 2022 - 2032F |
6.1.4 Israel Viral Vectors and Plasmid DNA Market Revenues & Volume, By Viral Vectors, 2022 - 2032F |
6.1.5 Israel Viral Vectors and Plasmid DNA Market Revenues & Volume, By Non-viral Vectors, 2022 - 2032F |
6.2 Israel Viral Vectors and Plasmid DNA Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Viral Vectors and Plasmid DNA Market Revenues & Volume, By Cancers, 2022 - 2032F |
6.2.3 Israel Viral Vectors and Plasmid DNA Market Revenues & Volume, By Inherited Disorders, 2022 - 2032F |
6.2.4 Israel Viral Vectors and Plasmid DNA Market Revenues & Volume, By Viral Infections, 2022 - 2032F |
6.2.5 Israel Viral Vectors and Plasmid DNA Market Revenues & Volume, By Others, 2022 - 2032F |
7 Israel Viral Vectors and Plasmid DNA Market Import-Export Trade Statistics |
7.1 Israel Viral Vectors and Plasmid DNA Market Export to Major Countries |
7.2 Israel Viral Vectors and Plasmid DNA Market Imports from Major Countries |
8 Israel Viral Vectors and Plasmid DNA Market Key Performance Indicators |
8.1 Research and development expenditure in gene therapy and biotechnology sectors in Israel |
8.2 Number of clinical trials utilizing viral vectors and plasmid DNA in Israel |
8.3 Adoption rate of gene therapy treatments using viral vectors and plasmid DNA in Israel |
9 Israel Viral Vectors and Plasmid DNA Market - Opportunity Assessment |
9.1 Israel Viral Vectors and Plasmid DNA Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Israel Viral Vectors and Plasmid DNA Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Israel Viral Vectors and Plasmid DNA Market - Competitive Landscape |
10.1 Israel Viral Vectors and Plasmid DNA Market Revenue Share, By Companies, 2025 |
10.2 Israel Viral Vectors and Plasmid DNA Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here